New BIO report forecasts an uncertain future for the antibiotics sector

A new report examining the antibiotics landscape in the US has highlighted the need for public policy solutions as investments in the sector wane.

Antibiotic Resistance: Advances in Understanding and Drug ...

The antibiotic market is considered to be broken, because physicians often avoid using new, more expensive antibiotics until it is absolutely ...

New BIO Report Examines the State of Antibacterial Innovation

Current pipeline “insufficient” to meet the threat of AMR, policy reforms critically needed The Biotechnology Innovation Organization (BIO) ...

A Biomanufacturing Plan to Confront Future Biological Threats

One niche sector whose shortcomings were illuminated during the COVID-19 pandemic was that of contract development and manufacturing ...

New antibiotic agents in the pipeline and how they can help ...

The Antimicrobial Availability Task Force of the Infectious Diseases Society of America (IDSA) in its report found significant variability in development of new ...

Quantifying uncertainty about future antimicrobial resistance

The increase of multidrug resistance and resistance to last-line antibiotics is a major global public health threat.

Antibiotics: past, present and future - ScienceDirect.com

The UK Government-commissioned O'Neill report predicted that without urgent action 10 million people a year will die from drug resistant ...

Towards the sustainable discovery and development of new antibiotics

An ever-increasing demand for novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant ...

NATIONAL STRATEGY FOR COMBATING ANTIBIOTIC - CDC

Antibiotics that lose their effectiveness for treating human disease through antibiotic resistance must be replaced with new drugs. Alternatives to antibiotics ...

Drug-Resistant Infections: A Threat to Our Economic Future

❉ New market models for investment and access. WHO Global Action Plan ... Morocco—Oilseeds sector review report. Country Highlights prepared under the ...

Revitalizing the antibiotic pipeline - Carb-X

Quantifying Uncertainty about Future. Antimicrobial Resistance: Comparing Structured Expert Judgment and Statistical Forecasting. Methods ... industry: new.

Antibiotics in crisis: Current Biology - Cell Press

Bacterial infections resistant to antibiotics kill 23,000 people per year in the US alone, a recent report warns. This crisis is man-made, as misuse of the ...

Antibiotic Resistance — Problems, Progress, and Prospects

Persistent, costly failure to discover novel antibiotics that would be destined for short-term use even if they survived the regulatory approval ...

REPORT TO THE PRESIDENT ON COMBATING ANTIBIOTIC ...

For many decades, the problem was manageable as the growth of resistance was slow and the pharmaceutical industry continued to create new antibiotics. Over ...

progress in exploring new environments for novel antibiotics - Nature

More recent approaches such as using artificial intelligence to 'design' synthetic ligands to dock with molecular targets suggest that chemical ...

The Case for a Subscription Model to Tackle Antimicrobial Resistance

Almost 50% of antibiotic treatments globally are initiated with the wrong drug and without a proper diagnosis. Barriers to better practices ...

Time for a change in how new antibiotics are reimbursed

However, there is a lack of treatments for infections caused by multidrug resistant (MDR) pathogens and a weak development pipeline of new therapies. One core ...

Tackling Drug-Resistant Infections Globally - AMR Review

95 Review on AMR, Securing new drugs for future generations: The pipeline of antibiotics,. 2015. to emerge more quickly than commercial drug developers can.

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on ...

Antibiotics have revolutionized medicine, saving countless lives since their discovery in the early 20th century. However, the origin of antibiotics is now ...

Phage Therapy: Past, Present and Future

Antimicrobial resistance (AMR) has made it so that, for a growing number of bacterial pathogens, the success rate of antibiotics is iffy, ...